Michael Kao

700 total citations
15 papers, 555 citations indexed

About

Michael Kao is a scholar working on Molecular Biology, Cancer Research and Biomedical Engineering. According to data from OpenAlex, Michael Kao has authored 15 papers receiving a total of 555 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 3 papers in Cancer Research and 3 papers in Biomedical Engineering. Recurrent topics in Michael Kao's work include Advanced biosensing and bioanalysis techniques (4 papers), Advanced Biosensing Techniques and Applications (3 papers) and Hedgehog Signaling Pathway Studies (2 papers). Michael Kao is often cited by papers focused on Advanced biosensing and bioanalysis techniques (4 papers), Advanced Biosensing Techniques and Applications (3 papers) and Hedgehog Signaling Pathway Studies (2 papers). Michael Kao collaborates with scholars based in United States, South Africa and China. Michael Kao's co-authors include Zhenan Bao, David G. Mackanic, Eduardo Méndez, Jeffrey B.‐H. Tok, Ahmed Diab, Michael Y. Sha, Klint A. Rose, Frank Y.S. Chuang, Satinderpall S. Pannu and Sharron G. Penn and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Angewandte Chemie International Edition and Journal of Clinical Oncology.

In The Last Decade

Michael Kao

15 papers receiving 543 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Kao United States	10	281	190	117	114	103	15	555
Zhixiang Tong United States	17	188 0.7×	229 1.2×	75 0.6×	89 0.8×	66 0.6×	23	738
Lingling Xiong China	10	203 0.7×	208 1.1×	76 0.6×	51 0.4×	78 0.8×	19	627
Yanling Jin China	13	178 0.6×	96 0.5×	102 0.9×	259 2.3×	165 1.6×	55	712
Zheng-Zheng Shi China	13	398 1.4×	163 0.9×	61 0.5×	47 0.4×	29 0.3×	27	785
Junfeng Shi United States	14	420 1.5×	469 2.5×	60 0.5×	75 0.7×	33 0.3×	19	937
Yu Xiong China	12	151 0.5×	140 0.7×	24 0.2×	31 0.3×	60 0.6×	21	425
Rubén Spretz United States	8	146 0.5×	195 1.0×	103 0.9×	26 0.2×	51 0.5×	10	555
Di‐Yen Chueh Taiwan	12	130 0.5×	260 1.4×	79 0.7×	66 0.6×	17 0.2×	16	509
Shuaishuai Liu China	7	204 0.7×	90 0.5×	65 0.6×	58 0.5×	20 0.2×	12	453
Ly James Lee United States	19	329 1.2×	328 1.7×	66 0.6×	32 0.3×	21 0.2×	30	843

Countries citing papers authored by Michael Kao

Since Specialization

Citations

This map shows the geographic impact of Michael Kao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Kao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Kao more than expected).

Fields of papers citing papers by Michael Kao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Kao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Kao. The network helps show where Michael Kao may publish in the future.

Co-authorship network of co-authors of Michael Kao

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Kao. A scholar is included among the top collaborators of Michael Kao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Kao. Michael Kao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

1.

Diab, Ahmed, Jherek Swanger, Michael Kao, et al.. (2020). FOXM1 drives HPV+ HNSCC sensitivity to WEE1 inhibition. Proceedings of the National Academy of Sciences. 117(45). 28287–28296. 23 indexed citations

2.

Mackanic, David G., Michael Kao, & Zhenan Bao. (2020). Enabling Deformable and Stretchable Batteries. Advanced Energy Materials. 10(29). 184 indexed citations

3.

Diab, Ahmed, et al.. (2019). Multiple Defects Sensitize p53-Deficient Head and Neck Cancer Cells to the WEE1 Kinase Inhibition. Molecular Cancer Research. 17(5). 1115–1128. 27 indexed citations

4.

Xu, Chang, Olga Nikolova, Ryan Basom, et al.. (2018). Functional Precision Medicine Identifies Novel Druggable Targets and Therapeutic Options in Head and Neck Cancer. Clinical Cancer Research. 24(12). 2828–2843. 19 indexed citations

5.

Méndez, Eduardo, Cristina P. Rodriguez, Michael Kao, et al.. (2018). A Phase I Clinical Trial of AZD1775 in Combination with Neoadjuvant Weekly Docetaxel and Cisplatin before Definitive Therapy in Head and Neck Squamous Cell Carcinoma. Clinical Cancer Research. 24(12). 2740–2748. 79 indexed citations

6.

Kao, Michael, et al.. (2018). The importance of technical skills assessment during an airway foreign body removal course. International Journal of Pediatric Otorhinolaryngology. 117. 1–5. 4 indexed citations

7.

Méndez, Eduardo, Cristina P. Rodriguez, Michael Kao, et al.. (2017). A phase I clinical trial of AZD1775 in combination with neoadjuvant weekly cisplatin and docetaxel in borderline resectable head and neck squamous cell carcinoma (HNSCC).. Journal of Clinical Oncology. 35(15_suppl). 6034–6034. 2 indexed citations

8.

Kao, Michael, et al.. (2017). Strategies for Targeted Therapy in Head and Neck Squamous Cell Carcinoma Using WEE1 Inhibitor AZD1775. JAMA Otolaryngology–Head & Neck Surgery. 143(6). 631–631. 12 indexed citations

9.

Moser, Russell, Chang Xu, Michael Kao, et al.. (2014). Functional Kinomics Identifies Candidate Therapeutic Targets in Head and Neck Cancer. Clinical Cancer Research. 20(16). 4274–4288. 66 indexed citations

10.

Xu, Chang, Yan Liu, Pei Wang, et al.. (2012). Integrative Analysis in Oral Squamous Cell Carcinoma Reveals DNA Copy Number–Associated miRNAs Dysregulating Target Genes. Otolaryngology. 147(3). 501–508. 16 indexed citations

11.

Kao, Michael, et al.. (2006). Generating short peptidic ligands for silver nanowires from phage display random libraries. Bioorganic & Medicinal Chemistry Letters. 16(20). 5261–5264. 7 indexed citations

12.

Tok, Jeffrey B.‐H., Frank Y.S. Chuang, Michael Kao, et al.. (2006). Metallic Striped Nanowires as Multiplexed Immunoassay Platforms for Pathogen Detection. Angewandte Chemie International Edition. 45(41). 6900–6904. 94 indexed citations

13.

Tok, Jeffrey B.‐H., Frank Y.S. Chuang, Michael Kao, et al.. (2006). Titelbild: Metallic Striped Nanowires as Multiplexed Immunoassay Platforms for Pathogen Detection (Angew. Chem. 41/2006). Angewandte Chemie. 118(41). 6921–6921. 1 indexed citations

14.

Tok, Jeffrey B.‐H., Frank Y.S. Chuang, Michael Kao, et al.. (2006). Metallic Striped Nanowires as Multiplexed Immunoassay Platforms for Pathogen Detection. Angewandte Chemie. 118(41). 7054–7058. 8 indexed citations

15.

Bi, Lanrong, Ming Zhao, Chao Wang, et al.. (2005). Stereoselective synthesis and anti-inflammatory activities of 6- and 7-membered dioxacycloalkanes. Bioorganic & Medicinal Chemistry. 14(5). 1339–1347. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact